Status:
COMPLETED
Defining Inflammation Related to Peritoneal Carcinomatosis in Women With Ovarian or Colon Cancer.
Lead Sponsor:
University of Pisa
Conditions:
Peritoneal Carcinomatosis
Ovarian Cancer
Eligibility:
FEMALE
25-75 years
Brief Summary
Inflammation plays an important role in the pathogenesis of peritoneal carcinosis. Patients with elevated levels of different inflammation cytokines show a worse prognosis at the time of diagnosis. In...
Detailed Description
At the time of hospitalization all the patients will undergo a complete clinical evaluation with determination of biochemical parameters such as fasting blood glucose, blood count, hs-CRP, AST and ALT...
Eligibility Criteria
Inclusion
- histological diagnosis of peritoneal carcinosis secondary to colon cancer or high-grade ovarian cancer
- patients able to consent
Exclusion
- previous malignancies, except for patients with cutaneous basal cell carcinoma, Cervical Intraepithelial Neoplasia (CIN) or melanoma in situ
- current chemotherapy or radiotherapy
- current steroid therapy or immunotherapy
- patients affected by systemic inflammatory disease and/or Inflammatory bowel disease (IBD)
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04122937
Start Date
March 1 2017
End Date
March 30 2019
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pisa
Pisa, Italy, 56125